A Transdiagnostic Study of Effort-Cost Decision-Making in Psychotic and Mood Disorders.

Adam J Culbreth, Erin K Moran, Wasita Mahaphanit, Molly A Erickson, Megan A Boudewyn, Michael J Frank, Deanna M Barch, Angus W MacDonald, J Daniel Ragland, Steven J Luck, Steven M Silverstein, Cameron S Carter, James M Gold
Author Information
  1. Adam J Culbreth: Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore, USA. ORCID
  2. Erin K Moran: Department of Psychological and Brain Sciences, Washington University in St. Louis, Saint Louis, USA. ORCID
  3. Wasita Mahaphanit: Department of Psychological and Brain Sciences, Dartmouth College, Hanover, USA.
  4. Molly A Erickson: Department of Psychiatry and Behavioral Neuroscience, University of Chicago, Chicago, USA.
  5. Megan A Boudewyn: Department of Psychology, University of California, Santa Cruz, USA.
  6. Michael J Frank: Department of Cognitive, Linguistics, and Psychological Sciences, Brown University, Providence, USA.
  7. Deanna M Barch: Department of Psychological and Brain Sciences, Washington University in St. Louis, Saint Louis, USA. ORCID
  8. Angus W MacDonald: Department of Psychology, University of Minnesota, Minneapolis, USA.
  9. J Daniel Ragland: Department of Psychiatry, University of California, Davis, School of Medicine, Davis, USA.
  10. Steven J Luck: Center for Mind and Brain, University of California, Davis, Davis, USA. ORCID
  11. Steven M Silverstein: Department of Psychiatry, University of Rochester Medical Center, Rochester, USA. ORCID
  12. Cameron S Carter: Department of Psychiatry, University of California, Davis, School of Medicine, Davis, USA.
  13. James M Gold: Department of Psychiatry, Maryland Psychiatric Research Center, University of Maryland, School of Medicine, Baltimore, USA. ORCID

Abstract

BACKGROUND: Research suggests that effort-cost decision-making (ECDM), the estimation of work required to obtain reward, may be a relevant framework for understanding motivational impairment in psychotic and mood pathology. Specifically, research has suggested that people with psychotic and mood pathology experience effort as more costly than controls, and thus pursue effortful goals less frequently. This study examined ECDM across psychotic and mood pathology.
HYPOTHESIS: We hypothesized that patient groups would show reduced willingness to expend effort compared to controls.
STUDY DESIGN: People with schizophrenia (N���=���33), schizoaffective disorder (N���=���28), bipolar disorder (N���=���39), major depressive disorder (N���=���40), and controls (N���=���70) completed a physical ECDM task. Participants decided between completing a low-effort or high-effort option for small or larger rewards, respectively. Reward magnitude, reward probability, and effort magnitude varied trial-by-trial. Data were analyzed using standard and hierarchical logistic regression analyses to assess the subject-specific contribution of various factors to choice. Negative symptoms were measured with a clinician-rated interview.
STUDY RESULTS: There was a significant effect of group, driven by reduced choice of high-effort options in schizophrenia. Hierarchical logistic regression revealed that reduced choice of high-effort options in schizophrenia was driven by weaker contributions of probability information. Use of reward information was inversely associated with motivational impairment in schizophrenia. Surprisingly, individuals with major depressive disorder and bipolar disorder did not differ from controls.
CONCLUSIONS: Our results provide support for ECDM deficits in schizophrenia. Additionally, differences between groups in ECDM suggest a seemingly similar behavioral phenotype, reduced motivation, could arise from disparate mechanisms.

Keywords

References

  1. Clin Psychol Sci. 2020 May 1;8(3):555-568 [PMID: 33758684]
  2. Schizophr Res. 2020 Oct;224:133-140 [PMID: 33046339]
  3. Biol Psychiatry. 2013 Jul 15;74(2):130-6 [PMID: 23394903]
  4. Schizophr Bull. 2015 Sep;41(5):1055-65 [PMID: 26209546]
  5. Eur Psychiatry. 2017 Oct;46:57-64 [PMID: 29031122]
  6. Am J Psychiatry. 2013 Feb;170(2):165-72 [PMID: 23377637]
  7. Biol Psychiatry Glob Open Sci. 2021 Mar 13;1(1):70-77 [PMID: 36324430]
  8. JAMA Psychiatry. 2023 Jun 1;80(6):548-557 [PMID: 37043223]
  9. Cogn Neuropsychiatry. 2015;20(2):172-85 [PMID: 25559619]
  10. J Affect Disord. 2021 Mar 15;283:254-261 [PMID: 33571794]
  11. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Oct;8(10):1041-1049 [PMID: 37290745]
  12. Braz J Psychiatry. 2022 Mar-Abr;44(2):147-155 [PMID: 34320125]
  13. Ann Fam Med. 2011 Jul-Aug;9(4):305-11 [PMID: 21747101]
  14. Psychol Med. 2018 Apr;48(6):889-904 [PMID: 28889803]
  15. Curr Opin Behav Sci. 2018 Aug;22:1-6 [PMID: 29607387]
  16. Schizophr Res. 2019 Feb;204:427-429 [PMID: 30172594]
  17. JAMA Psychiatry. 2013 Dec;70(12):1276-86 [PMID: 24089086]
  18. Curr Opin Psychiatry. 2015 Jan;28(1):7-12 [PMID: 25415499]
  19. J Abnorm Psychol. 2019 Oct;128(7):710-722 [PMID: 31282687]
  20. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2649-65 [PMID: 24035741]
  21. Schizophr Bull. 2015 Mar;41(2):503-12 [PMID: 25053653]
  22. Biol Psychiatry. 2023 Sep 15;94(6):501-510 [PMID: 37080416]
  23. World J Psychiatry. 2015 Dec 22;5(4):352-61 [PMID: 26740926]
  24. Neuropsychologia. 2018 Sep;118(Pt B):54-67 [PMID: 28689673]
  25. Psych J. 2020 Apr;9(2):210-222 [PMID: 31692266]
  26. Schizophr Res. 2016 Jan;170(1):198-204 [PMID: 26701649]
  27. Schizophr Res. 2015 Oct;168(1-2):483-90 [PMID: 26215506]
  28. J Affect Disord. 2016 May 15;196:97-100 [PMID: 26919058]
  29. Schizophr Bull. 2017 Jul 1;43(4):712-719 [PMID: 28969356]
  30. J Affect Disord. 2022 Jun 15;307:294-300 [PMID: 35339572]
  31. Psychiatry Res. 2014 Dec 30;220(3):874-82 [PMID: 25262638]
  32. J Psychopathol Clin Sci. 2023 May;132(4):490-498 [PMID: 37079841]
  33. Eur Arch Psychiatry Clin Neurosci. 2022 Aug;272(5):859-871 [PMID: 35079855]
  34. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  35. Nat Rev Neurosci. 2018 Aug;19(8):470-484 [PMID: 29946157]
  36. J Abnorm Psychol. 2014 May;123(2):387-97 [PMID: 24886012]
  37. J Abnorm Psychol. 2012 Aug;121(3):553-8 [PMID: 22775583]
  38. Biol Psychiatry. 2015 Dec 1;78(11):747-53 [PMID: 26049208]

Grants

  1. K23 MH126986/NIMH NIH HHS
  2. R01 MH084821/NIMH NIH HHS

MeSH Term

Humans
Mood Disorders
Depressive Disorder, Major
Decision Making
Psychotic Disorders
Schizophrenia
Motivation
Reward

Word Cloud

Created with Highcharts 10.0.0schizophreniaECDMdisorderrewardcontrolsreducedpsychoticmoodpathologyefforthigh-effortchoiceeffort-costdecision-makingmotivationalimpairmentgroupsSTUDYbipolarmajordepressivemagnitudeprobabilitylogisticregressiondrivenoptionsinformationmotivationBACKGROUND:ResearchsuggestsestimationworkrequiredobtainmayrelevantframeworkunderstandingSpecificallyresearchsuggestedpeopleexperiencecostlythuspursueeffortfulgoalslessfrequentlystudyexaminedacrossHYPOTHESIS:hypothesizedpatientshowwillingnessexpendcomparedDESIGN:PeopleN���=���33schizoaffectiveN���=���28N���=���39N���=���40N���=���70completedphysicaltaskParticipantsdecidedcompletinglow-effortoptionsmalllargerrewardsrespectivelyRewardvariedtrial-by-trialDataanalyzedusingstandardhierarchicalanalysesassesssubject-specificcontributionvariousfactorsNegativesymptomsmeasuredclinician-ratedinterviewRESULTS:significanteffectgroupHierarchicalrevealedweakercontributionsUseinverselyassociatedSurprisinglyindividualsdifferCONCLUSIONS:resultsprovidesupportdeficitsAdditionallydifferencessuggestseeminglysimilarbehavioralphenotypearisedisparatemechanismsTransdiagnosticStudyEffort-CostDecision-MakingPsychoticMoodDisordersexperimentalpsychopathologyprocessingtransdiagnostic

Similar Articles

Cited By

No available data.